Methadone in cancer pain management: Individualize dose and titrate to effect

被引：27

作者：

Foley, KM ^{[1
]}

Houde, RW ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1998年 / 16卷 / 10期

关键词：

D O I：

10.1200/JCO.1998.16.10.3213

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3213 / 3215

页数：3

共 27 条

[1]

BEAVER WT, 1967, CLIN PHARMACOL THER, V8, P415

[2]

Cherny N. J., 1995, CANCER, V76, P1288

[3]

CREWS JC, 1993, CANCER-AM CANCER SOC, V72, P2266, DOI 10.1002/1097-0142(19931001)72:7<2266::AID-CNCR2820720734>3.0.CO

[4]

2-P

[5] Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients [J].

DeConno, F ;

Groff, L ;

Brunelli, C ;

Zecca, E ;

Ventafridda, V ;

Ripamonti, C .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) :2836-2842

[6] DEXTROMETHORPHAN ATTENUATES AND REVERSES ANALGESIC TOLERANCE TO MORPHINE [J].

ELIOTT, K ;

HYNANSKY, A ;

INTURRISI, CE .

PAIN, 1994, 59 (03) :361-368

[7] METHADONE IN THE MANAGEMENT OF CANCER PAIN - A REVIEW [J].

FAINSINGER, R ;

SCHOELLER, T ;

BRUERA, E .

PAIN, 1993, 52 (02) :137-147

[8] Intravenous high-dose methadone administered by patient controlled analgesia and continuous infusion for the treatment of cancer pain refractory to high-dose morphine [J].

Fitzgibbon, DR ;

Ready, LB .

PAIN, 1997, 73 (02) :259-261

[9]

Foley Kathleen M., 1997, P2807

[10]

FOLEY KM, 1993, SYMP PAIN R, P331

← 1 2 3 →